Commense Overview

  • Founded
  • 2016

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Commense General Information


Developer of microbiome-derived therapeutics platform intended to promote a lifetime of good health. The company's microbiome-derived therapeutics platform focuses on preventing and treating diseases through microbiome-based treatments in infancy and early childhood, enabling physicians to protect babies born via C-section from the future onset of a variety of serious conditions.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 501 Boylston Street
  • Suite 6102
  • Boston, MA 02116
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Commense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Dec-2018 Completed Out of Business
1. Buyout/LBO 01-Oct-2017 Completed Startup
To view Commense’s complete valuation and funding history, request access »